A REMEDY-led international panel has developed new guidelines based on the best available research, where studies from REMEDY (NOR-DRUM) are a central part of the knowledge base. The underlying question: Can proactive TDM improve treatment outcomes for adults with inflammatory bowel disease, inflammatory arthritis, or psoriasis using biologics compared to standard care?